Evidence map›Paper›PMID 37253782›Full record

ArticleNature communications2023

Transcriptional coactivation by EHMT2 restricts glucocorticoid-induced insulin resistance in a study with male mice.

Rebecca A Lee, Maggie Chang, Nicholas Yiv, Ariel Tsay, Sharon Tian, Danielle Li, Coralie Poulard, Michael R Stallcup, Miles A Pufall, Jen-Chywan Wang

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rebecca A LeeEndocrinology Graduate Program, University of California Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0002-4072-0665
Maggie ChangEndocrinology Graduate Program, University of California Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0002-4618-5958
Nicholas YivDepartment of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA, 94720, USA.
Ariel TsayDepartment of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0003-0320-8213
Sharon TianDepartment of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0002-3549-7569
Danielle LiDepartment of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0002-8385-7557
Coralie PoulardInserm U1052, Centre de Recherche en Cancérologie de Lyon, 28 Rue Laennec, 69000, Lyon, France.ORCID 0000-0003-4821-908X
Michael R StallcupDepartment of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, 90089, USA.
Miles A PufallDepartment of Biochemistry and Molecular Biology, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA.ORCID 0000-0002-7022-6916
Jen-Chywan WangEndocrinology Graduate Program, University of California Berkeley, Berkeley, CA, 94720, USA. walwang@berkeley.edu.ORCID 0000-0001-6030-6886
University of California, Berkeley · USInserm · FRUniversity of Iowa · USUniversity of Southern California · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Y. Chen · 1986 to 2026
$30.7M
Sphingosine-1-phosphate Signaling and the Chronic Glucocorticoid Exposure Induced Glucose Homeostasis DisorderR01DK131194 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI WANG, JEN-CHYWAN · 2021 to 2025
$2.0M
Glucocorticoid Receptor Coregulators and Insulin SensitivityR01DK124866 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI WANG, JEN-CHYWAN · 2021 to 2024
$1.6M
Regulation of Insulin sensitivity by Glucocorticoid-Angiopoietin-like 4-Ceramide AxisR01DK113019 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI WANG, JEN-CHYWAN · 2018 to 2021
$1.5M
NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK113019NIDDK NIH HHS R01 DK124866NIDDK NIH HHS R01 DK131194
6 · The paper itself

Abstract

The classical dogma of glucocorticoid-induced insulin resistance is that it is caused by the transcriptional activation of hepatic gluconeogenic and insulin resistance genes by the glucocorticoid receptor (GR). Here, we find that glucocorticoids also stimulate the expression of insulin-sensitizing genes, such as Irs2. The transcriptional coregulator EHMT2 can serve as a transcriptional coactivator or a corepressor. Using male mice that have a defective EHMT2 coactivation function specifically, we show that glucocorticoid-induced Irs2 transcription is dependent on liver EHMT2's coactivation function and that IRS2 play a key role in mediating the limitation of glucocorticoid-induced insulin resistance by EHMT2's coactivation. Overall, we propose a model in which glucocorticoid-regulated insulin sensitivity is determined by the balance between glucocorticoid-modulated insulin resistance and insulin sensitizing genes, in which EHMT2 coactivation is specifically involved in the latter process.

Indexed as

GlucocorticoidsHistone-Lysine N-MethyltransferaseInsulin ResistanceAnimalsInsulinMaleMetabolism, Inborn ErrorsMiceReceptors, GlucocorticoidGlucocorticoidsHistone-Lysine N-MethyltransferaseInsulinReceptors, Glucocorticoid

Identifiers

PMID37253782
PMCPMC10229547
OpenAlexW4378782739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.